Alpine is fortunate to have investors who understand the challenges and rewards of developing life-changing drugs.
OrbiMed is a leading investment firm dedicated exclusively to the healthcare sector with approximately $15 billion in assets under management. OrbiMed invests globally across the spectrum of healthcare companies, from venture capital start-ups to large multinational companies utilizing a range of private equity funds, public equity funds, royalty/debt funds, and other investment vehicles. OrbiMed maintains offices in New York City, Herzliya, San Francisco, Shanghai, and Mumbai. For more information visit orbimed.com
Founded in 1991, Frazier Healthcare Partners has been a leading U.S.-based, healthcare-focused investment firm providing private growth capital to healthcare companies. The firm has more than $2.9 billion in committed capital under management and has made investments in more than 170 companies ranging from early-stage venture investments to growth buyouts of profitable lower middle market companies. Frazier’s experienced team takes an active approach to helping build portfolio companies, leveraging their deep domain expertise and expansive network of healthcare executives, advisors, and industry thought leaders. For more information, visit frazierhealthcare.com
Alpine BioVentures is committed to building revolutionary healthcare companies. The venture capital firm brings a unique perspective to identify game-changing scientific ideas and actively build collaborative working relationships with scientists to speed innovative new treatments to patients. Alpine BioVentures was responsible for the formation and seed funding of Alpine Immune Sciences. For more information, visit AlpineBioVentures.com